China Health Group FY26 H1 profit before tax rises 9.17% to RMB 11.17 million; revenue climbs 6.17% to RMB 22.95 million

• China Health Group posted profit attributable to owners of RMB 9.5 million, up 9.16% year on year.
• Revenue rose 6.17% to RMB 23 million, with all turnover from post-marketing surveillance and real-world clinical research services.
• Profit before tax increased 9.17% to RMB 11.17 million, while gross margin held at about 64.53%.
• Net cash from operating activities climbed to RMB 12.04 million; cash and cash equivalents grew to RMB 33.85 million.
• Management flagged steady demand in post-marketing CRSO services; a biological sample testing lab equipped with UPLC-MS/MS was opened.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Health Group Inc. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260827-12303389), on August 27, 2026, and is solely responsible for the information contained therein.